PROKPROKIDNEY CORP.

Nasdaq prokidney.com


$ 3.79 $ -0.13 (-3.32 %)    

Thursday, 16-May-2024 15:59:54 EDT
QQQ $ 451.64 $ -0.92 (-0.2 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.09 (-0.21 %)
TLT $ 92.06 $ -0.09 (-0.1 %)
GLD $ 220.06 $ -0.86 (-0.39 %)
$ 3.79
$ 3.88
$ 3.78 x 500
$ 3.79 x 132
$ 3.74 - $ 3.88
$ 1.12 - $ 13.51
411,384
na
231.01M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-28-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 prokidney-q1-eps-016-remains-flat-yoy-exits-quarter-with-cash--equivalents-worth-329m

ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.25) by ...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 morgan-stanley-assumes-prokidney-at-equal-weight-announces-price-target-of-3

Morgan Stanley analyst Judah Frommer assumes ProKidney (NASDAQ:PROK) with a Equal-Weight rating and announces Price Target o...

 b-of-a-securities-downgrades-prokidney-to-neutral-lowers-price-target-to-2

B of A Securities analyst Jason Gerberry downgrades ProKidney (NASDAQ:PROK) from Buy to Neutral and lowers the price target ...

 prokidney-corp-files-for-mixed-shelf-offering-of-500m

-SEC Filing

 why-childrens-place-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.

 prokidney-announces-updated-positive-interim-diabetic-ckd-data-from-its-rmcl-002-phase-2-study

Updated positive interim Phase 2 data demonstrate potential efficacy of REACT to preserve kidney function in moderate and high-...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION